Brezina Paul R, Yunus Fahd N, Zhao Yulian
Division of Reproductive Endocrinology and Infertility, Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, USA.
J Reprod Infertil. 2012 Jan;13(1):3-11.
The number of couples seeking consultation for infertility problems has steadily increased over the past decade, affecting 10%-15% of the sexually active population. Abnormal semen production, a male factor infertility (MFI), is thought to be the cause of up to 50% of all infertilities in developed countries. There are potentially many different causes of male infertility, including hormonal, anatomical, and secondary to exposure to exogenous substances. In many cases of MFI, a definitive cause for abnormalities is never identified. Recently, the research community has given greater attention to identifying causes of MFI ranging from genetic Y chromosome microdeletions to mechanisms of environmental damage on sperm production. Still evolving, is a clear understanding of how many pharmaceutical medications may cause MFI, which is often treatable and reversible. In this review we will outline the data regarding various pharmaceutical medications that have been investigated as possible causes of MFI.
在过去十年中,寻求不孕问题咨询的夫妇数量稳步增加,影响了10%至15%的性活跃人群。精液生成异常,即男性因素不育(MFI),被认为是发达国家高达50%的不孕病例的原因。男性不育可能有许多不同原因,包括激素、解剖学因素以及接触外源性物质所致。在许多MFI病例中,异常的确切原因从未被查明。最近,研究界更加关注确定MFI的原因,从Y染色体微缺失到环境对精子生成的损害机制。对于有多少药物可能导致MFI(通常是可治疗和可逆的)的清晰认识仍在不断发展中。在本综述中,我们将概述有关各种已被研究作为MFI可能原因的药物的数据。